New injection aims to knock out hepatitis b virus in major trial
NCT ID NCT07282249
Summary
This large Phase 3 trial will test if a new injection called TVAX-008 can help control chronic hepatitis B. It will involve 630 adults who are already on standard antiviral medication. The main goal is to see if the treatment can reduce the hepatitis B virus and a key protein (HBsAg) to undetectable levels in the blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITISB are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.